Connect with us

Business

Top doctors in Toronto, Ottawa and Peel calling on Ford government to reimplement stay-at-home order – CityNews Toronto

Published

 on


The top doctors of three COVID-19 hot spots in Ontario are urging the province to impose tougher restrictions, including a stay-at-home order, to address a surge in new infections.

The chief medical officers of health for Toronto, Peel Region and Ottawa made the recommendations in a letter to Dr. David Williams, the province’s top doctor.

“A stay-at-home order issued by the province through an Emergency Order is necessary to prevent and mitigate large scale morbidity and mortality and irreparable strain on the health-care system,” said the letter signed by Dr. Eileen da Villa, Dr. Lawrence Loh and Dr. Vera Etches.

The letter comes just days after Premier Doug Ford’s government imposed a provincewide month-long shutdown that critics argue does not go far enough to address more transmissible variants of concern.


RELATED: Entire province moves into ‘shutdown,’ Toronto patios close


The three doctors also appealed to Williams to move schools to online learning in regions with significant COVID-19 outbreaks, remove businesses from the list of essential services, and implement 50 per cent staffing limits for those businesses deemed essential.

They also asked the government to impose travel restrictions between regions within Ontario and for the province to provide paid sick days to supplement the federal program.

The Ontario Medical Association also joined the calls for stricter measures and a stay-at-home order to address the increase in COVID-19 cases.

“The consequences of not doing so could include more people sick and dying than we have experienced thus far; so many so, that doctors could no longer care for everyone,” said Dr. Samantha Hill, the group’s president.

A chart shows that short-term case projections depend entirely on system-level public health measures and vaccinations.

Credit: Science Advisory and Modelling Consensus Tables

A spokeswoman for Health Minister Christine Elliott said the shutdown was aimed at dealing with the third wave of the pandemic, but noted it takes time for the intended effects of the measures to be realized due to the incubation period of the virus.

But some public health leaders appeared to have lost patience with the province’s approach.

Loh of Peel Region used his powers under Ontario’s public health legislation Monday to order local schools closed for in-person learning.

All schools in Brampton, Caledon and Mississauga will move to remote learning for at least two weeks, starting on Tuesday, Loh said.


RELATED: Schools in Mississauga, Brampton and Caledon closing Tuesday for 2 weeks


“With increasing case counts and the presence of variants of concern, we need to break chains of transmission and keep our schools safe,” Loh said in a statement.

The decision to close schools in the region did not sit well with Brampton Mayor Patrick Brown.

“Don’t close elementary schools. Vaccinate educators,” he tweeted Monday.

Instead of closing schools, Brown suggested closing workplaces like Amazon, food processing plants, big box stores and factories.

“If our supply chain can’t handle it, then vaccinate essential workers. Same old approach isn’t working,” he said.

The president of the Elementary Teachers’ Federation of Ontario said all schools in hot spot regions should move to online learning until all teachers can be vaccinated.

“As medical experts have said, there is no excuse—no valid reason—to not begin vaccinating all essential workers today; this includes all education workers,” Sam Hammond said in a statement.

A spokesperson from Education Minister Stephen Lecce said the province firmly believes that schools should remain open for in-class learning as they are critical for students’ metal health.


RELATED: TDSB, TCDSB and DPCDSB closing multiple schools due to COVID-19 outbreaks


Meanwhile, Toronto Mayor John Tory said the city was working on a plan to bring the COVID-19 vaccine to high-risk workplaces using mobile vaccination units.

Tory stressed that the plan was contingent on the availability of vaccine supply in the coming weeks.

“We hope to be able to take it to workplaces … where we know there’s a higher risk just given all the circumstances, and to other areas where we know people are more vulnerable,” Tory said.

Ontario’s vaccine rollout began in December and focused initially on immunizing some of the province’s oldest residents in long-term care and health-care workers.

In recent months, it has shifted in a descending order through the oldest age groups in the province, with Toronto now starting to give the shot to people 60 years and older at its six mass vaccination sites.

But increasingly, experts in the health-care sector say essential workers who cannot work from home and often cannot self-isolate if they contract the illness should be prioritized for the shot.

ICU doctors have said many of the patients they’re treating these days are essential workers who got infected in the workplace.

The province said 494 patients were in intensive care because of COVID-19 and 293 on a ventilator – 44 new patients were admitted in ICUs on Sunday.

Ontario reported nearly 6,000 new COVID-19 cases over a two-day span – 2,938 new cases on Monday and 3,041 cases on Sunday – and 22 deaths.

There were 942 people hospitalized with the virus during the same period, though the Ministry of Health noted that 10 per cent of Ontario’s hospitals do not submit data on weekends.

With files from Denise Paglinawan and Holly McKenzie-Sutter

Let’s block ads! (Why?)



Source link

Continue Reading

Business

CANADA STOCKS – TSX falls 0.14% to 19,201.28

Published

 on

* The Toronto Stock Exchange’s TSX falls 0.14 percent to 19,201.28

* Leading the index were Stantec Inc <STN.TO​>, up 3.4%, Imperial Oil Ltd​, up 3.3%, and Corus Entertainment Inc​, higher by 2.9%.

* Lagging shares were Aphria Inc​​, down 14.2%, Village Farms International Inc​, down 9.9%, and Aurora Cannabis Inc​, lower by 9.4%.

* On the TSX 91 issues rose and 134 fell as a 0.7-to-1 ratio favored decliners. There were 24 new highs and no new lows, with total volume of 228.0 million shares.

* The most heavily traded shares by volume were Toronto-dominion Bank, Royal Bank Of Canada and Suncor Energy Inc.

* The TSX’s energy group fell 0.32 points, or 0.3%, while the financials sector climbed 2.46 points, or 0.7%.

* West Texas Intermediate crude futures rose 0.52%, or $0.31, to $59.63 a barrel. Brent crude  rose 0.4%, or $0.25, to $63.2 [O/R]

* The TSX is up 10.1% for the year.

Continue Reading

Business

Air Canada signs C$5.9 billion government aid package, agrees to buy Airbus, Boeing jets

Published

 on

By David Ljunggren and Allison Lampert

OTTAWA/MONTREAL (Reuters) -Air Canada, struggling with a collapse in traffic due to the COVID-19 pandemic, reached a deal on Monday on a long-awaited aid package with the federal government that would allow it to access up to C$5.9 billion ($4.69 billion) in funds.

The agreement – the largest individual coronavirus-related loan that Ottawa has arranged with a company – was announced after the airline industry criticized Prime Minister Justin Trudeau’s Liberal government for dawdling. The United States and France acted much more quickly to help major carriers.

Canada‘s largest carrier, which last year cut over half its workforce, or 20,000 jobs, and other airlines have been negotiating with the government for months on a coronavirus aid package.

In February, Air Canada reported a net loss for 2020 of C$4.65 billion, compared with a 2019 profit of C$1.48 billion.

As part of the deal, Air Canada agreed to ban share buybacks and dividends, cap annual compensation for senior executives at C$1 million a year and preserve jobs at the current level, which is 14,859.

It will also proceed with planned purchases of 33 Airbus SE 220 airliners and 40 Boeing Co 737 MAX airliners.

Chris Murray, managing director, equity research at ATB Capital Markets, said the deal took into account the “specific needs of Air Canada in the short and medium term without being overly onerous.”

He added: “It gives them some flexibility in drawing down additional liquidity as needed.”

Transport Minister Omar Alghabra said the government was still in negotiations with other airlines about possible aid.

Canada, the world’s second-largest nation by area, depends heavily on civil aviation to keep remote communities connected.

Opposition politicians fretted that further delays in announcing aid could result in permanent damage to the country.

Air Canada said it would resume services on nearly all of the routes it had suspended because of COVID-19.

‘SIGNIFICANT LAYER OF INSURANCE’

The deal removes a potential political challenge for the Liberals, who insiders say are set to trigger an election later this year.

The government has agreed to buy C$500 million worth of shares in the airline, at C$23.1793 each, or a 14.2% discount to Monday’s close, a roughly 6% stake.

“Maintaining a competitive airline sector and good jobs is crucially important,” Finance Minister Chrystia Freeland told reporters, adding the equity stake would allow taxpayers to benefit when the airline’s fortunes recovered.

The Canadian government previously approved similar loans for four other companies worth up to C$1.billion, including up to C$375 million to low-cost airline Sunwing Vacations Inc. The government has paid out C$73.47 billion under its wage subsidy program and C$46.11 billion in loans to hard-hit small businesses.

Michael Rousseau, Air Canada‘s president and chief executive officer, said the liquidity “provides a significant layer of insurance for Air Canada.”

Jerry Dias, head of the Unifor private-sector union, described the announcement as “a good deal for everybody.”

Unifor represents more than 16,000 members working in the air transportation sector.

But the Canadian Union of Public Employees, which represents roughly 10,000 Air Canada flight attendants, said the package protected the jobs of current workers rather than the 7,500 members of its union who had been let go by the carrier.

($1=1.2567 Canadian dollars)

(Reporting by David Ljunggren in Ottawa and Allison Lampert in Montreal; Additional reporting by Julie Gordon in Ottawa and Munsif Vengattil in Bengaluru; Editing by Dan Grebler and Peter Cooney)

Continue Reading

Business

U.K. advises limiting AstraZeneca in under-30s amid clot worry

Published

 on

LONDON —
British authorities recommended Wednesday that the AstraZeneca COVID-19 vaccine not be given to adults under 30 where possible because of strengthening evidence that the shot may be linked to rare blood clots.

The recommendation came as regulators both in the United Kingdom and the European Union emphasized that the benefits of receiving the vaccine continue to outweigh the risks for most people — even though the European Medicines Agency said it had found a “possible link” between the shot and the rare clots. British authorities recommended that people under 30 be offered alternatives to AstraZeneca. But the EMA advised no such age restrictions, leaving it up to its member-countries to decide whether to limit its use.

Several countries have already imposed limits on who can receive the vaccine, and any restrictions are closely watched since the vaccine, which is cheaper and easier to store than many others, is critical to global immunization campaigns and is a pillar of the UN-backed program known as COVAX that aims to get vaccines to some of the world’s poorest countries.

“This is a course correction, there’s no question about that,” Jonathan Van-Tam, England’s deputy chief medical officer, said during a press briefing. “But it is, in a sense, in medicine quite normal for physicians to alter their preferences for how patients are treated over time.”

Van-Tam said the effect on Britain’s vaccination timetable — one of the speediest in the world — should be “zero or negligible,” assuming the National Health Service receives expected deliveries of other vaccines, including those produced by Pfizer and Moderna.

EU and U.K. regulators held simultaneous press conferences Wednesday afternoon to announce the results of investigations into reports of blood clots that sparked concern about the rollout of the AstraZeneca vaccine.

The EU agency described the clots as “very rare” side effects. Dr Sabine Straus, chair of EMA’s Safety Committee, said the best data is coming from Germany where there is one report of the rare clots for every 100,000 doses given, although she noted far fewer reports in the U.K. Still, that’s less than the clot risk that healthy women face from birth control pills, noted another expert, Dr. Peter Arlett.

The agency said most of the cases reported have occurred in women under 60 within two weeks of vaccination — but based on the currently available evidence, it was not able to identify specific risk factors. Experts reviewed several dozen cases that came mainly from Europe and the U.K., where around 25 million people have received the AstraZeneca vaccine.

“The reported cases of unusual blood clotting following vaccination with the AstraZeneca vaccine should be listed as possible side effects of the vaccine,” said Emer Cooke, the agency’s executive director. “The risk of mortality from COVID is much greater than the risk of mortality from these side effects.”

Arlett said there is no information suggesting an increased risk from the other major COVID-19 vaccines.

The EMA’s investigation focused on unusual types of blood clots that are occurring along with low blood platelets. One rare clot type appears in multiple blood vessels and the other in veins that drain blood from the brain.

While the benefits of the vaccine still outweigh the risks, that assessment is “more finely balanced” among younger people who are less likely to become seriously ill with COVID-19, the U.K’s Van-Tam said.

“We are not advising a stop to any vaccination for any individual in any age group,” said Wei Shen Lim, who chairs Britain’s Joint Committee on Vaccination and Immunization. “We are advising a preference for one vaccine over another vaccine for a particular age group, really out of the utmost caution rather than because we have any serious safety concerns.”

In March, more than a dozen countries, mostly in Europe, suspended their use of AstraZeneca over the blood clot issue. Most restarted — some with age restrictions — after the EMA said countries should continue using the potentially life-saving vaccine.

Britain, which relies heavily on AstraZeneca, however, continued to use it.

The suspensions were seen as particularly damaging for AstraZeneca because they came after repeated missteps in how the company reported data on the vaccine’s effectiveness and concerns over how well its shot worked in older people. That has led to frequently changing advice in some countries on who can take the vaccine, raising worries that AstraZeneca’s credibility could be permanently damaged, spurring more vaccine hesitancy and prolonging the pandemic.

Dr. Peter English, who formerly chaired the British Medical Association’s Public Health Medicine Committee, said the back-and-forth over the AstraZeneca vaccine globally could have serious consequences.

“We can’t afford not to use this vaccine if we are going to end the pandemic,” he said.

In some countries, authorities have already noted hesitance toward the AstraZeneca shot.

“People come and they are reluctant to take the AstraZeneca vaccine, they ask us if we also use anything else,” said Florentina Nastase, a doctor and co-ordinator at a vaccination centre in Bucharest, Romania. “There were cases in which people (scheduled for the AstraZeneca) didn’t show up, there were cases when people came to the centre and saw that we use only AstraZeneca and refused (to be inoculated).”

Meanwhile, the governor of Italy’s northern Veneto region had said earlier Wednesday that any decision to change the guidance on AstraZeneca would cause major disruptions to immunizations — at a time when Europe is already struggling to ramp them up — and could create more confusion about the shot.

“If they do like Germany, and allow Astra Zeneca only to people over 65, that would be absurd. Before it was only for people under 55. Put yourself in the place of citizens, it is hard to understand anything,” Luca Zaia told reporters.

The latest suspension of AstraZeneca came in Spain’s Castilla y Leon region, where health chief Veronica Casado said Wednesday that “the principle of prudence” drove her to put a temporary hold on the vaccine that she still backed as being both effective and necessary.

French health authorities had said they, too, were awaiting EMA’s conclusions, as were some officials in Asia.

On Wednesday, South Korea said it would temporarily suspend the use of AstraZeneca’s vaccine in people 60 and younger. In that age group, the country is only currently vaccinating health workers and people in long-term care settings.

The Korea Disease Control and Prevention Agency said it would also pause a vaccine rollout to school nurses and teachers that was to begin on Thursday, while awaiting the outcome of the EMA’s review.

But some experts urged perspective. Prof Anthony Harnden, the deputy chair of Britain’s vaccination committee, said that the program has saved at least 6,000 lives in the first three months and will help pave the way back to normal life.

“What is clear it that for the vast majority of people the benefits of the Oxford AZ vaccine far outweigh any extremely small risk,” he said. “And the Oxford AZ vaccine will continue to save many from suffering the devastating effects that can result from a COVID infection.”

Source: – CTV News

Source link

Continue Reading

Trending